Abstract
Autophagy is a cellular process involved in the degradation and turn-over of long-lived proteins and organelles, which can be subjected to suppression or further induction in response to different stimuli. According to its essential role in cellular homeostasis, autophagy has been implicated in several pathologies including cancer, neurodegeneration and myopathies. More recently, autophagy has been described as a mechanism of both innate and adaptive immunity against intracellular bacteria and viruses. In this context, autophagy has been proposed as a protective mechanism against viral infection by degrading the pathogens into autolysosomes. This is strengthened by the fact that several proteins involved in interferon (IFN) signalling pathways are linked to autophagy regulation. However, several viruses have evolved strategies to divert IFN-mediated pathways and autophagy to their own benefit. This review provides an overview of the autophagic process and its involvement in the infection by different viral pathogens and of the connections existing between autophagy and proteins involved in IFN signalling pathways.
Similar content being viewed by others
Introduction
Cellular homeostasis requires a highly regulated equilibrium between protein synthesis and proteolysis, and its deregulation has been implicated in several pathologies. Two major pathways are involved in the degradation of macromolecules in eukaryotes: the ubiquitin/proteasome pathway and autophagy. The former is involved in the constitutive degradation of short-lived proteins, maintaining a continuous protein turn-over in the cell [1]. Autophagy, which literally means “to eat oneself”, is necessary for the lysosomal degradation and recycling of long-lived proteins and entire organelles [2]. This process has been observed in all eukaryotes and is morphologically identical in plants, yeasts and animals. Autophagy can be classified into at least three different types: macroautophagy, microautophagy and chaperone-mediated autophagy (CMA). The last one is the only autophagic process that is not conserved through evolution and exits only in higher eukaryotes. The first CMA substrate identified was ribonuclase A and a particular motif in this protein, KFERQ, was shown necessary for its selective degradation. This motif is recognised by the chaperone protein Hsc70 and targeted to lysosomal membranes where Hsc70 interacts with the lysosomal membrane protein (lamp) type 2a. The substrates are then translocated to the lysosomal lumen where they are degraded. It is now known that all the CMA substrates contain a KFERK-like motif, which is recognised by the hsc70. This motif is composed of a basic (K, R), an acidic (D, E), a hydrophobic (F, I, L, V), and another basic or hydrophobic amino acid and is flanked by a Q on either side [3]. Microautophagy is characterised by the invagination of the lysosomal membrane that sequesters cytoplasmic constituents and, subsequently, degradation of the sequestered material. Macroautophagy is the major lysosomal route for the turnover of cytoplasmic constituents, and will hereafter be referred as autophagy. This process begins with an engulfment event of portions of the cytosol into a characteristic double-membrane vacuole, called the autophagosome. After maturation, autophagosomes fuse with lysosomes for the degradation of the sequestered material by lysosomal hydrolases. This last event allows the recycling of the degraded constituents [4, 5].
Autophagy is a highly regulated mechanism involving specific genes called Atg (autophagy-related genes). Although this process has been identified for more than 40 years, the first understandings of its molecular mechanisms dated from about 10 years, with the discovery of Atg genes in yeast and orthologs in humans [6]. Interestingly, it has been shown recently that the ubiquitin/proteasome pathway and autophagy are connected. Indeed, Atg7 knock-out mice present an accumulation of ubiquitinated aggregates. This observation suggests that, in addition to the proteasome pathway, ubiquitinated proteins can be removed by autophagy [7]. Moreover, it may also reflect a compensatory mechanism in the absence of autophagy.
Even if the origin of the lipids that compose autophagosomes has been an aspect extensively studied since the discovery of autophagy, this question is still hotly debated [8]. The first studies provided evidence that the source of autophagosomal membranes was both the Golgi and the endoplasmic reticulum and, at present, the endoplasmic reticulum is the most probable one [9]. Another possibility is that the membranes are unique or formed de novo [10]. Thus, it has been proposed that, in mammals, autophagosomes derived from a unique membrane of unknown origin, called the phagophore. Furthermore, a novel structure necessary for autophagosome formation, called the pre-autophagosomal structure (PAS), has been identified in yeast [11].
According to its essential role in cellular homeostasis, autophagy has been implicated in several pathologies including cancer, neurodegeneration and myopathies [12]. More recently, autophagy has been described as a mechanism of innate immunity against intracellular pathogens [13], and its implication in major histocompatibility complex (MHC) class II antigen presentation extends its function in adaptive immunity [13–15]. The term immunophagy has recently been proposed by Deretic [13] for the specialised role of autophagy in immunity. A new field of investigation is now emerging about the role of autophagy in viral infections. Besides its role as an intracellular host defence pathway against viruses, autophagy can also be used by the virus for its own profit to replicate more efficiently in the cells, or to control cell survival [16]. The term virophagy could be used to define the relationships that exist between autophagy and viral infections. In this paper, presented are the different molecular steps of the autophagic process, its implication in both cell survival and cell death and the relationships that are known between autophagy and viral infections.
Overview
Molecular mechanisms of the autophagic process
In all eucaryotes, autophagy occurs as a house-keeping mechanism in normal growing conditions. In animal cells, it is subjected to suppression or further induction in response to different stresses, starvation, specific hormones or other stimuli [17–20]. The discovery of Atg genes has been essential in the molecular understanding of this process. A major challenge in the autophagy field is now to decipher the signalling pathways that act downstream the initial autophagy induction signals. Basically, the autophagic process can be divided into different steps: activation, autophagosome formation, targeting to and fusion with lysosomes and breakdown [21] (Fig. 1).
Activation
In mammalian cells, the autophagic Beclin 1 protein (ortholog of yeast Atg6) functions as part of a class III phosphatidylinositol 3-kinase (PI3K) complex and plays a crucial role in the early steps of autophagosome formation [22, 23]. The mammalian class III PI3K/Beclin 1 complex has its yeast counterpart that consists in the association of Vps34 (the ortholog of class III PI3K) with the autophagic proteins Atg6 and Atg14 [22]. The mammalian counterpart of Atg14 has not been identified so far. Recent data suggest that other proteins belong to this complex and thus regulate the outcome of the signalling via class III PI3K. Indeed, Bcl-2 can negatively regulate the activation of autophagy through its interaction with Beclin 1 [24]. Recently, an activator of autophagy, called UVRAG (UV irradiation resistance-associated gene), has been identified to be part of the PI3K/Beclin 1 complex and to represent an important signalling checkpoint in autophagy and tumour-cell growth [25].
Autophagosome formation
The autophagic process depends on two ubiquitin-like conjugation systems essential for autophagosome formation [26] (Fig. 2). In general, three different enzymes are required for the process of conjugation: an E1-activating enzyme, an E2-conjugating enzyme and an E3 ligase enzyme. The first conjugation system mediates formation of the conjugate Atg12/Atg5. Atg12 is activated by the E1-like enzyme Atg7, and then Atg12 is transferred to the E2-like enzyme Atg10. Finally, Atg12 is covalently linked to a specific lysine of Atg5. No E3-like enzyme has been discovered to date. Then, the conjugate Atg12/Atg5 interacts non-covalently with Atg16L (Atg16 in yeast) to trigger homo-oligomerisation, leading to the formation of a macromolecular complex of approximately 800 kDa (350 kDa in yeast) necessary for the formation of autophagosomes. This structure is associated with the outer side of the autophagosomes in formation and dissociates from membranes before the autophagosome completion. The second conjugation system is original because it consists in the conjugation of a protein to a lipid, resulting in the formation of the Atg8/PE (phosphatidyl-ethanolamin) conjugate. Atg8 is a soluble cytoplasmic protein that must be first proteolysed by Atg4 to enter the conjugation system. After maturation by Atg4, Atg8 is activated by the E1-like enzyme Atg7, and then transferred to the E2-like enzyme Atg3. Finally, Atg8 is covalently linked to PE. This conjugate is present in both sides of the autophagosomes and seems fundamental for its completion. After autophagosome completion, the Atg8 molecules present at the cytoplasmic face of this structure are recycled after cleavage by Atg4 and the remaining Atg8 proteins present in the inner membrane of autophagosomes are degraded after fusion with lysosomes. There are several orthologs of Atg8 in mammalian cells: MAP-LC3, GATE-16 and GABARAP, each representing a different subfamily [27]. Among these proteins, MAP-LC3 is the best characterised one and represents the most useful marker for autophagosome identification [28, 29]. In addition, there are four mammalian orthologs of Atg4, called autophagins, but only autophagin 1 (also called hAtg4B) cleaves specifically Atg8 and its different mammalian orthologs [30, 31]. Interestingly, it appears that these two conjugation systems are connected. Indeed, the Atg5/Atg12-Atg16 complex is necessary for the formation of the second conjugate [32]. Moreover, overexpression of Atg10 facilitates the maturation of MAP-LC3, overexpression of Atg3 facilitates the conjugation of Atg12 to Atg5, and excess amount of the Atg12-Atg5 conjugate inhibits the MAP-LC3 maturation [33].
In yeast, another complex is involved in autophagosome formation, which requires the autophagic proteins Atg9 and Atg2. Atg9, the only transmembrane autophagic protein so far identified, is necessary for the formation of the PAS but is absent in the mature autophagosomes [34]. mAtg9, the human ortholog of the yeast Atg9 has been shown to traffic between the Golgi and endosomes, suggesting an involvement of the Golgi complex in the autophagic pathway [35].
Targeting to and fusion with lysosomes
After completion, autophagosomes can fuse in yeast with the vacuole, or in mammals with the lysosomes to form autolysosomes, using the same molecular fusion machinery. Before fusing with lysosomes, autophagosomes can also fuse with endosomes to form amphisomes, making a direct connection between the endo-lysosomal and autophagic pathways [36]. Membrane fusion can be delineated into different steps: tethering, docking and fusion of the membrane bilayers. Tethering and docking events are facilitated by multi-protein complexes, and the specificity of the events is provided by GTPases from the Rab family. In particular, the GTPase Rab7 is required for the final maturation of late autophagic vacuoles and thus for the progression of the autophagic process [37, 38]. Fusion is driven by assembly of pairs of membrane proteins called SNAREs on each fusion partner [39]. Using bafilomycin A1, an inhibitor of vacuolar H+ ATPase (V-ATPase), it has been shown that acidification of the lumenal space of autophagosomes or lysosomes by V-ATPase is an important step for the fusion between autophagosomes and lysosomes [40].
Breakdown
After the fusion step with lysosomes, the cytoplasmic material sequestered in autophagosomes is released in the lysosomal lumen and subsequently consumed by hydrolases. This event requires the acidic pH of the lysosome to efficiently break the inner membrane of the autolysosome. In yeast, the involvement of the lipase Atg15, which is delivered to the vacuole through the multivesicular bodies, is required for vesicle breakdown [41]. After degradation of the sequestered material, the constituents are recycled through lysosomal transporters toward the cytosol. Recently, the yeast protein Atg22 has been shown to mediate the efflux of leucine and other amino acids resulting from autophagic degradation [42].
Signalling pathways involved in the regulation of autophagy
The mammalian serine/threonine protein kinase target of rapamycin (MTOR) is a key regulator that controls autophagy triggering and is often called “the gate keeper of the autophagic pathway” [43, 44]. This kinase senses environmental changes to modulate autophagy. Several proteins act positively or negatively on mTOR and, by this way, influence the autophagic process. The cascade upstream mTOR includes class I PI3K and Akt, whereas the phosphatase and tension homolog (PTEN) acts antagonistically to the class I PI3K to induce autophagy. Rapamycin, a specific inhibitor of mTOR, activates autophagy whereas amino acids are inhibitors of this process. However, the precise mechanisms involved in the negative regulation of autophagy by amino acids remain an open question.
Induction of autophagy by nutrient starvation is better characterised in yeast than in mammals. Indeed, it has been shown that under nutrient-rich conditions, the autophagic protein Atg13 is highly phosphorylated in response to the TOR kinase activation. This phosphorylation status provides a lower affinity of Atg13 for the autophagic serine/threonine protein kinase Atg1, repressing autophagy. In contrast, under nutrient-deficient conditions, or following treatment with the TOR inhibitor rapamycin, Atg13 is rapidly and partially dephosphorylated, resulting in an interaction of high affinity with Atg1. In these conditions, the autophagic activity is increased [45]. A putative ortholog of the yeast Atg1, called ULK1, has been identified in mammals. This protein seems to be involved in the localization of the mAtg9 [46]. It is worth noting that Atg13 is not conserved in mammals.
Finally, other signalling pathways independent of mTOR have been involved in the regulation of autophagy [47, 48].
Other regulators of the autophagic pathway are the eIF2α kinases. They belong to an evolutionarily conserved serine/threonine kinase family that regulates stress-induced translational arrest. It has been demonstrated that the yeast eIF2α kinase GCN2 and the eIF2α-regulated transcriptional transactivator GCN4 are essential for starvation-induced autophagy [49]. It is worth noting that GCN2 is conserved in mammals, suggesting that this protein may have a similar role in higher eukaryotes. Recently, endoplasmic reticulum stress induced by poly-glutamine 72 repeat (polyQ72) has been shown to induce autophagy after activation of the eIF2α kinase PKR-endoplasmic reticulum-related kinase (PERK) activation [50]. In contrast, another study has reported that the autophagic process triggered in response to endoplasmic reticulum stress is PERK-independent [51]. The mammalian interferon (IFN)-inducible eIF2α kinase PKR (protein kinase RNA-activated) plays also an important role in triggering autophagy [49]. As PKR is a protein essential in cellular response to viral infections, this point will be discussed in more details afterwards [52].
Dual role of autophagy in cell survival and cell death
Autophagy is a cellular mechanism essential for homeostasis. It has been extensively studied for its ability to maintain cells alive in response to starvation. This theory has been confirmed since then by studies demonstrating increased cell death in cells or organisms lacking gene products essential for autophagy [53]. A good example to illustrate this aspect is the demonstration of the role of autophagy during the early neonatal starvation period. Indeed, at birth, the placental nutrient supply is interrupted, and neonates face starvation until the first feeding by milk. It has been shown that autophagy is up-regulated in various tissues during this period, and those mice incompetent for autophagy (Atg5 knock-out mice) die within 1 day after birth [54]. In addition, autophagy has been shown to play a critical role in maintaining cellular bioenergetics and survival during growth factor deprivation in cells incompetent for apoptosis [55]. Furthermore, it has been shown that inhibition of autophagy triggers apoptotic cell death under conditions of nutrient depletion [56].
Despite its role in cell survival, an extensive body of literature highlights the fact that autophagy can also be considered as a cell death pathway (type II programmed cell death, PCD). Autophagic cell death can be distinguished from apoptosis (type I PCD) by morphological criteria, i.e. the presence of autophagosomes in dying cells. Cell death with autophagic features can occur in cells lacking critical apoptosis executioners, indicating that autophagy can compensate for defect apoptosis [57]. Autophagic cell death has also been described after treatment with chemotherapeutic drugs [58]. However, cell death, characterised by hallmarks of both type I PCD and type II PCD, is frequently observed; thus, making a clear-cut difference between them is difficult [59–62].
The autophagic protein Beclin 1, which has first been identified as a Bcl-2 interacting protein, has haplo-insufficient tumour suppressor functions. Its gene mapped to a tumour susceptibility locus on chromosome 17q21 that is monoallelically deleted in 40 to 75% of cases of sporadic breast, ovarian and prostate cancers [63]. It has been recently shown that Bcl-2 negatively regulates Beclin 1-dependent autophagy and Beclin 1-dependent autophagic cell death, connecting the two types of PCD [24]. A new link between these death processes has been described by Crighton et al. [64], as a p53 target gene encoding a lysosomal protein, called DRAM (damage-regulated autophagy modulator), is also an inducer of autophagy.
As autophagy appears essential in the cell fate between life and death, it is not surprising that it has been implicated in numerous pathologies, including neurodegenerative diseases, infectious diseases and cancer. This dual role has been very well described in several reviews [44, 65–67].
Autophagy and viral infections
Both bacteria and viruses can be targeted to autophagic degradation [67, 68]. The best-characterised examples for autophagy of pathogens, also termed xenophagy, are engulfment of Mycobacterium tuberculosis in phagosomes [69], trapping of cytosolic group A Streptococci in autophagosomes [70] and immune escape by Shigella [71]. Moreover, it has been shown recently that Staphylococcus aureus can use autophagy for its replication before inducing an autophagic host cell death [72].
In this review, we focus on the role of autophagy in the replication of different viruses.
Autophagy is now recognised as a mechanism of immunity against microbes that invade eukaryotic cells. On one hand, evidences indicate that autophagy is involved in the delivery of cytosolic antigens to the MHC class II pathway. Indeed, antigens are processed before binding to MHC class II molecules within endosomal and lysosomal compartments of antigen-presenting cells for subsequent presentation to T cells [73]. Autophagy is also involved to digest endogenously synthesised viral proteins, allowing their processing for MHC II presentation and thus connecting autophagy with adaptive immunity [14]. On the other hand, the autophagic process allows the sequestration of pathogens inside the autophagosomes, leading to their destruction by lysosomes.
Beside its important role in the immune response against pathogens, very well described by Schmid et al. in [15], autophagy plays also a direct role in the life cycle of viruses.
Autophagy and viral infection in plants
In plants, the hypersensitive response (HR) is a complex, early defence response that causes necrosis and cell death at the infection site to restrict the growth of a pathogen. The HR is also thought to deprive the pathogens of a supply of food and thus to confine them to the initial infection site [74]. In addition, the HR could regulate the defence responses of the plant in both local and distant tissues [75].
It has been suggested that autophagy acts as an antiviral mechanism since Beclin 1- or Atg7-silenced plants present an accumulation of tobacco mosaic virus (TMV) at infection sites. Interestingly, induction of autophagy is not only restricted to the TMV infection sites but is also extended to uninfected adjacent tissues where autophagy protects cells from death. In this case, autophagy would play a pro-survival role by blocking pathogen spread and bystander cell death [76]. At present, no other studies connecting plant viruses and autophagy have been done.
Autophagy and viral infections in mammals
Autophagy has been first proposed as a protective mechanism against viral infection by degrading the pathogens in autolysosomes. Its antiviral role is strengthened by the fact that IFN signalling pathways are involved in autophagy induction. Indeed, IFNs are a family of multifunctional secreted cytokines that have been characterised by their ability to interfere with virus infection and replication [77]. However, several viruses have evolved strategies to divert IFN-mediated pathways and autophagy to their own benefit [16].
Table 1 summarised the different data available about the connections between autophagy and viral infections in mammals and higher plants.
Herpes simplex virus type I (HSV-1)
Herpes simplex virus type I (HSV-1) belongs to the herpes virus family. It is a double-stranded DNA virus that resides in a latent state in sensory neurons. During an attack, the virus grows down the nerves and out into the skin or mucous membranes where it multiplies, causing the clinical lesions [78].
It is well characterised that the HSV-1 neurovirulence ICP34.5 protein (infected cell protein 34.5) plays a crucial role in viral infection by inducing the dephosphorylation of the translation initiation factor eIF-2α, and thus negating the PKR antiviral activity [79, 80]. In accordance with the role of the PKR-eIF-2α pathway in the positive regulation of autophagy, wild type HSV-1-infected cells do not present any autophagosomes. However, HSV-1 mutants that do not express ICP34.5 are able to trigger autophagy in infected cells, leading to viral degradation. Moreover, the same mutant viruses that infect cells in which PKR is not expressed exhibit a normal viral replication, demonstrating that ICP34.5 is able to block autophagy by inhibiting the PKR antiviral activity in infected cells [81]. These results demonstrate that HSV-1 has evolved strategies to counteract cellular antiviral functions [82].
Poliovirus and rhinoviruses
Poliovirus and rhinovirus belong to the picornavirus family. They are lytic non-enveloped viruses whose RNA genome is translated, replicated, and packaged in the cytoplasm of infected cells. The poliovirus, responsible for poliomyelitis, invades the nervous system, and the onset of paralysis can occur in a matter of hours. Rhinoviruses are the most common viral infective agents in humans, and a causative agent of the common cold.
In poliovirus-infected cells, it has been observed, early after infection, an accumulation of membranous structures in the cytoplasm [83]. These structures are composed of double-membranes and contain markers of the entire secretory pathway, including the rough endoplasmic reticulum, the Golgi apparatus and lysosomes. This suggests that these double-membrane structures originate from a process analogous to the formation of autophagic vacuoles [84]. More recently, MAP-LC3 and LAMP-1 have been found localised in poliovirus- and rhinovirus-induced vesicles in infected cells. More precisely, the co-expression of two poliovirus-encoded proteins called 2BC and 3A triggers MAP-LC3 and LAMP1 co-localization. Moreover, inhibition of the autophagic process using siRNA directed against the autophagic proteins LC3 and Atg12 decreases both intracellular and extracellular virus yield. The authors suggested that poliovirus and rhinovirus infection induce the formation of autophagosome-like structures to serve as membrane scaffolds for RNA replication and to inhibit their maturation into degradative organelles [85]. Because of the presence of both LC3 and the poliovirus capsid protein VP1 in extracellular structures adjacent to poliovirus-infected cells, Jackson et al. speculate that viral particles may be released by a non-lytic pathway using autophagosome-like vesicles. It has also been suggested that autophagosomes, which can become single-membraned upon maturation, provide a mechanism for the non-lytic release of cytoplasmic viruses and possibly other cytoplasmic material [86]. Very recently, the Arf family of small GTPases, which controls secretory trafficking, has been shown to associate with the newly formed membrane structures used for viral RNA replication after poliovirus infection [87].
Human immunodeficiency virus type I (HIV-1)
The human immunodeficiency virus type I (HIV-1) is a member of the retrovirus family. HIV-1 infection usually leads to progressive decline in functionality and number of CD4 T lymphocytes, resulting in AIDS development [88]. As early as 1991, apoptosis has been proposed as a possible mechanism responsible for CD4 T cell depletion in patients infected with HIV-1, and an extensive body of literature since then has supported this hypothesis [89]. In HIV-1-infected patients, both infected and uninfected cells undergo accelerated apoptosis, in vitro and in vivo. However, HIV-1-induced apoptosis in bystander uninfected immune cells is likely the major event leading to the depletion of CD4 T lymphocytes since the degree of cell loss largely exceeds the number of infected cells. Furthermore, the vast majority of T cells undergoing apoptosis in peripheral blood and lymph nodes of HIV patients are uninfected [90]. HIV-1 infection is mediated by the binding of envelope glycoproteins (Env) to the receptor CD4 and a co-receptor, mainly CCR5 or CXCR4. Notably, binding of Env, expressed on HIV-1-infected cells, to CXCR4, triggers apoptosis of uninfected CD4 T cells. Very recently, we have demonstrated that, independently of HIV-1 replication, Env-transfected or HIV-1-infected cells that express Env at the cell surface induce autophagy and accumulation of Beclin 1 in uninfected CD4 T lymphocytes, process dependent on the presence of CXCR4. Moreover, autophagy is a prerequisite to Env-induced apoptosis in uninfected bystander T cells, and CD4 T cells still undergo an Env-mediated cell death with autophagic features when apoptosis is inhibited [62, 91]. To the best of our knowledge, these findings represent the first example of autophagy triggered through binding of viral envelope proteins on target cells, without viral replication, and leading to apoptosis. At present, we do not know the significance of Env-induced Beclin 1 accumulation in CD4 T cell death and if autophagy has a role in HIV-1-replication, and these points are currently under investigation in the laboratory.
It has been shown that HIV-1 uses cytoplasmic late endosomal structures, identified as MVBs, for its budding step, suggesting that HIV-1 may use components of the autophagic machinery for its replication cycle [92]. In contrast, a recent study suggests that the initiating site for constitutive HIV-1 assembly and release is not the endosomal structure but the plasma membrane [93]. Thus, observation of HIV-1 particles in MVBs may be considered as a cellular defence mechanism that restricts the HIV-1 replication cycle by degrading assembled virions.
Sindbis virus
The Sindbis virus, which provokes encephalitis, belongs to the togavirus family. Its genome is a linear, single-stranded RNA. Sindbis-infected apoptotic cell death is closely linked to viral replication. Indeed, the antiapoptotic Bcl-2 protein protects neurons from virus-induced cell death and decreases viral replication in the central nervous system [94]. To explore the role of Bcl-2 in this context, a yeast two-hybrid screen has been performed and has permitted to identify the autophagic protein Beclin 1 as a Bcl-2 interacting protein in infected cells. The brains of mice infected with a recombinant virus that expresses Beclin 1 show fewer Sindbis virus RNA-positive cells, fewer apoptotic cells, and lower viral titers than the brains of mice infected with recombinant viruses that express a Beclin 1 protein deleted in its Bcl-2 interacting domain, or Beclin 1 containing a premature stop codon. These results provide evidence of an antiviral activity of the autophagic protein Beclin 1 [95]. However, no further studies have been done on the role of the entire autophagic process in the reduction in Sindbis virus infection.
The human B19 parvovirus
B19 belongs to the parvovirus family whose genome is a single-stranded DNA. It infects erythroid cells and causes several diseases including aplastic crisis in patients with haemolytic anemia, erythema infectiosum and hydrops fetalis [96]. B19 infection induces cell cycle arrest at G1 and G2/M phases and apoptosis mediated by a viral non-structural protein called NS1 [97]. Recently, it has been shown that autophagy is induced in human parvovirus B19-infected cells arrested in G2 phase, before they are competent for viral replication, leading to infected-cell survival. These results suggest that autophagy may benefit B19 in allowing viral multiplication before cell collapse [98].
Coronavirus
Coronaviruses are enveloped positive sense RNA viruses that replicate entirely in the cytoplasm of cells. They are the cause of many domesticated animal diseases and are responsible for up to 30% of human colds. A new human coronavirus has recently been identified as the causative agent of the severe acute respiratory syndrome (SARS). Murine hepatitis virus (MHV), which belongs to the coronavirus family, is frequently used to study the formation and function of the viral replication complexes. These complexes present a punctate perinuclear localisation and their number and size increase over the course of infection. Moreover, MHV RNA replication occurs on cytoplasmic double-membrane vesicles whose membranes are issued from the rough endoplasmic reticulum [99]. The co-localization of late endosomal proteins and LC3 with viral RNA-replication proteins on these membranes argues for their derivation from the autophagic pathway [99]. Importantly, the formation of autophagosome-like structures seems beneficial for MHV viral production. Indeed, the yield of extracellular virus is diminished 1,000-fold in clonal isolates of Atg5−/− mouse embryonic stem cells. In addition, expression of ectopic Atg5 in these cells restores the wild-type yield [99]. These results demonstrate that Atg5, which is crucial for the autophagic pathway, is required for the production of infectious MHV virions. In consequences, the autophagic pathway may be required for the formation of double-membrane-bound MHV replication complexes and, by this way, may significantly enhance the efficiency of replication. However, the exact role of Atg5 in this process is not fully determined. It would be interesting to know if Atg5 benefits to MHV only by inducing the formation of autophagic membranes or if it has a more specific function in the viral replication cycle.
In SARS-infected cells, the early formation and accumulation of typical double-membrane vesicles, which probably carry the viral replication, have been observed by electron microscopy. Opposite to what was described for MHV, morphological and labelling studies argued against the previously proposed involvement of the autophagic pathway as the source for the vesicles, and instead suggested the endoplasmic reticulum to be the most likely donor of the membranes that carry the SARS replication complex [100].
Rotavirus
Rotavirus belongs to the reovirus family whose genome is a dsRNA. Infection with this virus is the first cause of infantile gastroenteritis. Rotavirus nonstructural protein 4 (NSP4) has functions in viral morphogenesis and pathogenesis. A recent report shows that inhibition of NSP4 expression by small interfering RNAs leads to alteration of the production and distribution of other viral proteins and mRNA synthesis, suggesting that NSP4 also affects virus replication.
In rotavirus-infected cells, it has been shown that NSP4 co-localises with LC3 in structures associated with the sites of nascent viral RNA replication. This report suggests that autophagy may be involved in rotavirus replication [101]. However, the precise role of this process in rotavirus infection needs further investigations.
Bovine viral diarrhoea virus (BVDV)
Bovine viral diarrhoea virus (BVDV) belongs to the flavivirus family whose genome is a ssRNA. The genomic RNA contains one long open reading frame that is translated into a polyprotein. This polyprotein is processed by cellular and virus-encoded proteases. BVDV-infection represents an economically important cause of disease of farm animals. The mucosal desease (MD) is the most severe clinical condition resulting from infection by BVDV. Both a cytopathogenic virus (cp-BVDV) and a non-cytopathogenic virus (noncp-BVDV) are required for induction of MD. Infection with noncp-BVDV occurs intra-utero, leading to a specific immunotolerance. The disease is induced by super-infection with a cp-BVDV or by generation of a cp-mutant of the persisting noncp-virus. In most cases, RNA recombination is responsible for the switch from a noncp- to a cp-virus.
Several types of cellular insertions, which code for ubiquitin, different ubiquitin-like proteins, a protein of unknown function or a part of LC3, have been found. Naturally occurring noncp-viruses express the fusion protein NS2-3, but further processing gives rise to both proteins NS2 and NS3, only present in cp-BVDV. Interestingly, it has been shown that LC3 inserted in the polyprotein of a naturally occurring mutant BVDV served as a proteolytic processing signal by a cellular protease related to Atg4, allowing the expression of the viral NS3 protein. These data provide evidence of the use of autophagy proteins for the expression of viral proteins, linked to the pathology [102].
Interferon system and autophagy
IFNs are a family of multifunctional secreted cytokines that have been characterised by their ability to inhibit virus infection and replication [77]. They can be divided in two sub-groups: IFN type I (α,β) and IFN type II (γ). After their secretion, IFNs bind to specific cell surface receptors and act in paracrine and autocrine ways to induce expression of more than 200 genes called IFN-stimulated genes (ISGs). The large majority of them are still not characterised and their involvement in the IFN system is very fragmentary. ISGs are the effectors of the IFN functions, namely antiviral, antiproliferative, immunomodulatory and apoptotic functions [77]. All these effects of IFNs seem to converge towards the most known IFN activity that is an antiviral function. In consequence, it is not surprising that many viruses have evolved strategies to circumvent the IFN antiviral response and even use IFN-induced processes to replicate more efficiently [103].
Interestingly, beside the fact that IFNγ can induce autophagic vacuole formation, several proteins known to be involved in triggering autophagy are involved in the IFN response [104]. Among them, we can mention the double-stranded RNA-dependent PKR, the death-associated protein kinase and DAPK-related protein-1 (DAPK and DRP-1), the TNF-related apoptosis inducing ligand (TRAIL) and the Fas-associated death domain (FADD).
dsRNA-dependent protein kinase (PKR)
PKR is a serine–threonine protein kinase inactive at a basal level and whose activity can be stimulated by different inducers. It has been first associated with the antiviral action of IFNs [105]. It can be activated by dsRNA, a common intermediate in the replication of many viruses [106]. After interaction with dsRNA, PKR undergoes conformational changes that trigger its autophosphorylation and thus its activation. The major substrate of PKR is the α-subunit of eukaryotic translation initiation factor eIF2α, resulting in inhibition of protein synthesis [107]. However, PKR can be activated without viral dsRNA or viral infection by different stresses or through protein-protein interactions. For instance, PKR can be activated by interacting with the protein PKR activating protein (PACT), leading to apoptosis [108].
The role of PKR in autophagy triggering is mediated by its capacity to inhibit protein translation through eIF-2α phosphorylation. At present, HSV-1 is the only virus known to inhibit induction of PKR-dependent autophagy, through action of the viral protein ICP34.5 [82]. As a large number of viruses are able to inhibit dsRNA-mediated PKR activation and eIF2α phosphorylation, it would be interesting to analyse their role in autophagy regulation [68].
Death-associated protein kinase: DAPk and DRP-1
DAPk is a calcium–calmodulin (CaM)-regulated serine/threonine kinase involved in IFNγ-mediated cell death [109]. Four additional kinases of the family have been identified according to homologies with DAPk in the catalytic domain [110]. DRP-1 is one of the closest family members, as its catalytic domains share approximately 80% identity to those of DAPk. It has been shown that expression of DAPk or DRP-1 in cells induces morphological changes associated with membrane blebbing and mediates a caspase-independent cell death pathway with formation of autophagic vesicles that are characteristic of type II programmed cell death [111].
TNF-receptor apoptosis induced ligand (TRAIL)
TRAIL, also called Apo2L, initiates apoptosis of tumour cells by binding to either of its receptors, DR4 or DR5.
Using an in vitro morphogenesis model, in which MCF-10A human mammary epithelial cells form hollow acini-like structures, it has been demonstrated that TRAIL is required for the induction of autophagy. The authors demonstrated that both apoptotic cell death and autophagic cell death are required to eliminate the cells during the lumen formation [112].
Fas-associated death domain (FADD)
FADD protein belongs to the death-inducing signalling complex (DISC) that transmits apoptotic signals through activation of caspase-8 [113]. It has been demonstrated that FADD is involved in IFNγ-induced autophagic cell death. In this study, Pyo and collaborators have demonstrated that Atg5 mediates IFNγ-induced vacuole formation and subsequent cell death through interaction with FADD [104]. Moreover, recent data has identified a novel cell death pathway activated by FADD that combines apoptosis and autophagy and that is selectively inactivated at the earliest stages of epithelial cancer development [114].
Conclusion
Considering these data, it becomes clear that autophagy is a fundamental and general process playing a role in viral infections. Indeed, this process is involved in both adaptive and innate immunity, contributing to clearance of intracellular pathogens, and in cell survival or cell death. Moreover, viruses are able to evolve strategies to counteract or to exploit autophagy to their own profit. Indeed, several viruses can block autophagy triggering to avoid their destruction in autolysosomes. In contrast, other viruses use autophagosomes to their own replication. Unravelling the specific role of autophagy in different viral infections would be a crucial step in the understanding of the pathogenesis.
Finally, knowledge of the relationships between autophagy and the antiviral IFNs open new routes of investigation. As a large number of IFN-inducible proteins have still no known biological function, it would be very interesting to determine their role in autophagy triggering.
The interplay between the autophagic pathway and the viral life cycle is thus complex and needs a better comprehension to provide new antiviral therapeutics.
References
Glickman MH, Ciechanover A (2002) The ubiquitin–proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82:373–428
Yorimitsu T, Klionsky DJ (2005) Autophagy: molecular machinery for self-eating. Cell Death Differ 12(Suppl 2):1542–1552
Massey AC, Zhang C, Cuervo AM (2006) Chaperone-mediated autophagy in aging and disease. Curr Top Dev Biol 73:205–235
Klionsky DJ (2005) Autophagy. Curr Biol 15:R282–R283
Cuervo AM (2004) Autophagy: many paths to the same end. Mol Cell Biochem 263:55–72
Tsukada M, Ohsumi Y (1993) Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. FEBS Lett 333:169–174
Komatsu M, Waguri S, Ueno T et al (2005) Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol 169:425–434
Juhasz G, Neufeld TP (2006) Autophagy: a forty-year search for a missing membrane source. PLoS Biol 4:e36
Dunn WA Jr (1990) Studies on the mechanisms of autophagy: formation of the autophagic vacuole. J Cell Biol 110:1923–1933
Ashford TP, Porter KR (1962) Cytoplasmic components in hepatic cell lysosomes. J Cell Biol 12:198–202
Seglen PO, Berg TO, Blankson H, Fengsrud M, Holen I, Stromhaug PE (1996) Structural aspects of autophagy. Adv Exp Med Biol 389:103–111
Marino G, Lopez-Otin C (2004) Autophagy: molecular mechanisms, physiological functions and relevance in human pathology. Cell Mol Life Sci 61:1439–1454
Deretic V (2006) Autophagy as an immune defense mechanism. Curr Opin Immunol 18:375–382
Dengjel J, Schoor O, Fischer R et al (2005) Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc Natl Acad Sci USA 102:7922–7927
Schmid D, Dengjel J, Schoor O, Stevanovic S, Munz C (2006) Autophagy in innate and adaptive immunity against intracellular pathogens. J Mol Med 84:194–202
Colombo MI (2005) Pathogens and autophagy: subverting to survive. Cell Death Differ 12(Suppl 2):1481–1483
Kurmasheva RT, Houghton PJ (2006) IGF-I mediated survival pathways in normal and malignant cells. Biochim Biophys Acta 1766:1–22
Yin VP, Thummel CS (2005) Mechanisms of steroid-triggered programmed cell death in Drosophila. Semin Cell Dev Biol 16:237–243
Kadowaki M, Razaul Karim M, Carpi A, Miotto G (2006) Nutrient control of macroautophagy in mammalian cells. Mol Aspects Med 27:426–443
Heymann D (2006) Autophagy: a protective mechanism in response to stress and inflammation. Curr Opin Investig Drugs 7:443–450
Wang CW, Klionsky DJ (2003) The molecular mechanism of autophagy. Mol Med 9:65–76
Kihara A, Kabeya Y, Ohsumi Y, Yoshimori T (2001) Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep 2:330–335
Zeng X, Overmeyer JH, Maltese WA (2006) Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking. J Cell Sci 119:259–270
Pattingre S, Tassa A, Qu X et al (2005) Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122:927–939
Liang C, Feng P, Ku B et al (2006) Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol 8:688–699
Mizushima N, Noda T, Yoshimori T et al (1998) A protein conjugation system essential for autophagy. Nature 395:395–398
Kabeya Y, Mizushima N, Yamamoto A, Oshitani-Okamoto S, Ohsumi Y, Yoshimori T (2004) LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J Cell Sci 117:2805–2812
Mizushima N (2004) Methods for monitoring autophagy. Int J Biochem Cell Biol 36:2491–2502
Klionsky DJ (2005) The correct way to monitor autophagy in higher eukaryotes. Autophagy 1:65
Marino G, Uria JA, Puente XS, Quesada V, Bordallo J, Lopez-Otin C (2003) Human autophagins, a family of cysteine proteinases potentially implicated in cell degradation by autophagy. J Biol Chem 278:3671–3678
Hemelaar J, Lelyveld VS, Kessler BM, Ploegh HL (2003) A single protease, Apg4B, is specific for the autophagy-related ubiquitin-like proteins GATE-16, MAP1-LC3, GABARAP, and Apg8L. J Biol Chem 278:51841–51850
Mizushima N, Ohsumi Y, Yoshimori T (2002) Autophagosome formation in mammalian cells. Cell Struct Funct 27:421–429
Tanida I, Ueno T, Kominami E (2004) LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol 36:2503–2518
Noda T, Kim J, Huang WP et al (2000) Apg9p/Cvt7p is an integral membrane protein required for transport vesicle formation in the Cvt and autophagy pathways. J Cell Biol 148:465–480
Webber JL, Young AR, Tooze SA (2007) Atg9 Trafficking in Mammalian Cells. Autophagy 3:54–56
Berg TO, Fengsrud M, Stromhaug PE, Berg T, Seglen PO (1998) Isolation and characterization of rat liver amphisomes. Evidence for fusion of autophagosomes with both early and late endosomes. J Biol Chem 273:21883–21892
Gutierrez MG, Munafo DB, Beron W, Colombo MI (2004) Rab7 is required for the normal progression of the autophagic pathway in mammalian cells. J Cell Sci 117:2687–2697
Jager S, Bucci C, Tanida I et al (2004) Role for Rab7 in maturation of late autophagic vacuoles. J Cell Sci 117:4837–4848
Klionsky DJ (2005) The molecular machinery of autophagy: unanswered questions. J Cell Sci 118:7–18
Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R, Tashiro Y (1998) Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct 23:33–42
Teter SA, Eggerton KP, Scott SV, Kim J, Fischer AM, Klionsky DJ (2001) Degradation of lipid vesicles in the yeast vacuole requires function of Cvt17, a putative lipase. J Biol Chem 276:2083–2087
Yang Z, Huang J, Geng J, Nair U, Klionsky DJ (2006) Atg22 recycles amino acids to link the degradative and recycling functions of autophagy. Mol Biol Cell 17:5094–5104
Yang YP, Liang ZQ, Gu ZL, Qin ZH (2005) Molecular mechanism and regulation of autophagy. Acta Pharmacol Sin 26:1421–1434
Codogno P, Meijer AJ (2005) Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ 12(Suppl 2):1509–1518
Kamada Y, Sekito T, Ohsumi Y (2004) Autophagy in yeast: a TOR-mediated response to nutrient starvation. Curr Top Microbiol Immunol 279:73–84
Young AR, Chan EY, Hu XW et al (2006) Starvation and ULK1-dependent cycling of mammalian Atg9 between the TGN and endosomes. J Cell Sci 119:3888–3900
Yamamoto A, Cremona ML, Rothman JE (2006) Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway. J Cell Biol 172:719–731
Sarkar S, Rubinsztein DC (2006) Inositol and IP3 levels regulate autophagy: biology and therapeutic speculations. Autophagy 2:132–134
Talloczy Z, Jiang W, Virgin HWt et al (2002) Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway. Proc Natl Acad Sci USA 99:190–195
Kouroku Y, Fujita E, Tanida I et al (2007) ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ 14:230–239
Ogata M, Hino S, Saito A et al (2006) Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol 26:9220–9231
He B (2006) Viruses, endoplasmic reticulum stress, and interferon responses. Cell Death Differ 13:393–403
Clarke PG (1990) Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol (Berl) 181:195–213
Kuma A, Hatano M, Matsui M et al (2004) The role of autophagy during the early neonatal starvation period. Nature 432:1032–1036
Lum JJ, Bauer DE, Kong M et al (2005) Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120:237–248
Boya P, Gonzalez-Polo RA, Casares N et al (2005) Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 25:1025–1040
Bursch W, Ellinger A, Kienzl H et al (1996) Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis 17:1595–1607
Kondo Y, Kanzawa T, Sawaya R, Kondo S (2005) The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5:726–734
Debnath J, Baehrecke EH, Kroemer G (2005) Does autophagy contribute to cell death? Autophagy 1:66–74
Gonzalez-Polo RA, Boya P, Pauleau AL et al (2005) The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death. J Cell Sci 118:3091–3102
Djavaheri-Mergny M, Amelotti M, Mathieu J et al (2006) NF-kappaB activation represses tumor necrosis factor-alpha-induced autophagy. J Biol Chem 281:30373–30382
Espert L, Denizot M, Grimaldi M et al (2006) Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J Clin Invest 116:2161–2172
Aita VM, Liang XH, Murty VV et al (1999) Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 59:59–65
Crighton D, Wilkinson S, O’Prey J et al (2006) DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126:121–134
Hait WN, Jin S, Yang JM (2006) A matter of life or death (or both): understanding autophagy in cancer. Clin Cancer Res 12:1961–1965
Eskelinen EL (2005) Doctor Jekyll and Mister Hyde: autophagy can promote both cell survival and cell death. Cell Death Differ 12(Suppl 2):1468–1472
Levine B, Yuan J (2005) Autophagy in cell death: an innocent convict? J Clin Invest 115:2679–2688
Kirkegaard K, Taylor MP, Jackson WT (2004) Cellular autophagy: surrender, avoidance and subversion by microorganisms. Nat Rev Microbiol 2:301–314
Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, Deretic V (2004) Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119:753–766
Nakagawa I, Amano A, Mizushima N et al (2004) Autophagy defends cells against invading group A Streptococcus. Science 306:1037–1040
Ogawa M, Yoshimori T, Suzuki T, Sagara H, Mizushima N, Sasakawa C (2005) Escape of intracellular Shigella from autophagy. Science 307:727–731
Schnaith A, Kashkar H, Leggio S, Addicks K, Kronke M, Krut O (2007) Staphylococcus aureus subvert autophagy for induction of caspase-independent host cell death. J Biol Chem 282:2695–2706
Paludan C, Schmid D, Landthaler M et al (2005) Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307:593–596
Lam E (2004) Controlled cell death, plant survival and development. Nat Rev Mol Cell Biol 5:305–315
Morel JB, Dangl JL (1997) The hypersensitive response and the induction of cell death in plants. Cell Death Differ 4:671–683
Liu Y, Schiff M, Czymmek K, Talloczy Z, Levine B, Dinesh-Kumar SP (2005) Autophagy regulates programmed cell death during the plant innate immune response. Cell 121:567–577
Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD (1998) How cells respond to interferons. Annu Rev Biochem 67:227–264
Decman V, Freeman ML, Kinchington PR, Hendricks RL (2005) Immune control of HSV-1 latency. Viral Immunol 18:466–473
He B, Gross M, Roizman B (1997) The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 94:843–848
Leib DA (2002) Counteraction of interferon-induced antiviral responses by herpes simplex viruses. Curr Top Microbiol Immunol 269:171–185
Leib DA, Machalek MA, Williams BR, Silverman RH, Virgin HW (2000) Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc Natl Acad Sci USA 97:6097–6101
Talloczy Z, Virgin HWt, Levine B (2006) PKR-Dependent Autophagic Degradation of Herpes Simplex Virus Type 1. Autophagy 2:24–29
Dales S, Eggers HJ, Tamm I, Palade GE (1965) Electron microscopic study of the formation of poliovirus. Virology 26:379–389
Schlegel A, Giddings TH Jr, Ladinsky MS, Kirkegaard K (1996) Cellular origin and ultrastructure of membranes induced during poliovirus infection. J Virol 70:6576–6588
Jackson WT, Giddings TH Jr, Taylor MP et al (2005) Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol 3:e156
Kirkegaard K, Jackson WT (2005) Topology of double-membraned vesicles and the opportunity for non-lytic release of cytoplasm. Autophagy 1:182–184
Belov GA, Altan-Bonnet N, Kovtunovych G, Jackson CL, Lippincott-Schwartz J, Ehrenfeld E (2007) Hijacking components of the cellular secretory pathway for replication of poliovirus RNA. J Virol 81:558–567
Fauci AS (1988) The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239:617–622
Terai C, Kornbluth RS, Pauza CD, Richman DD, Carson DA (1991) Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 87:1710–1715
Finkel TH, Tudor-Williams G, Banda NK et al (1995) Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat Med 1:129–134
Espert L, Denizot M, Grimaldi M et al (2007) Autophagy and CD4(+) T Lymphocyte Destruction by HIV-1. Autophagy 3:32–34
Finzi A, Brunet A, Xiao Y, Thibodeau J, Cohen EA (2006) Major histocompatibility complex class II molecules promote human immunodeficiency virus type 1 assembly and budding to late endosomal/multivesicular body compartments. J Virol 80:9789–9797
Jouvenet N, Neil SJ, Bess C et al (2006) Plasma membrane is the site of productive HIV-1 particle assembly. PLoS Biol 4:e435
Levine B, Goldman JE, Jiang HH, Griffin DE, Hardwick JM (1996) Bc1-2 protects mice against fatal alphavirus encephalitis. Proc Natl Acad Sci USA 93:4810–4815
Liang XH, Kleeman LK, Jiang HH et al (1998) Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol 72:8586–8596
Chisaka H, Morita E, Yaegashi N, Sugamura K (2003) Parvovirus B19 and the pathogenesis of anaemia. Rev Med Virol 13:347–359
Morita E, Tada K, Chisaka H et al (2001) Human parvovirus B19 induces cell cycle arrest at G(2) phase with accumulation of mitotic cyclins. J Virol 75:7555–7563
Nakashima A, Tanaka N, Tamai K et al (2006) Survival of parvovirus B19-infected cells by cellular autophagy. Virology 349:254–263
Prentice E, Jerome WG, Yoshimori T, Mizushima N, Denison MR (2004) Coronavirus replication complex formation utilises components of cellular autophagy. J Biol Chem 279:10136–10141
Snijder EJ, van der Meer Y, Zevenhoven-Dobbe J et al (2006) Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J Virol 80:5927–5940
Berkova Z, Crawford SE, Trugnan G, Yoshimori T, Morris AP, Estes MK (2006) Rotavirus NSP4 induces a novel vesicular compartment regulated by calcium and associated with viroplasms. J Virol 80:6061–6071
Fricke J, Voss C, Thumm M, Meyers G (2004) Processing of a pestivirus protein by a cellular protease specific for light chain 3 of microtubule-associated proteins. J Virol 78:5900–5912
Haller O, Kochs G, Weber F (2006) The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344:119–130
Pyo JO, Jang MH, Kwon YK et al (2005) Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J Biol Chem 280:20722–20729
Hovanessian AG, Brown RE, Kerr IM (1977) Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells. Nature 268:537–540
Meurs E, Chong K, Galabru J et al (1990) Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62:379–390
Williams BR (1999) PKR; a sentinel kinase for cellular stress. Oncogene 18:6112–6120
Li S, Min JY, Krug RM, Sen GC (2006) Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349:13–21
Shohat G, Shani G, Eisenstein M, Kimchi A (2002) The DAP-kinase family of proteins: study of a novel group of calcium-regulated death-promoting kinases. Biochim Biophys Acta 1600:45–50
Inbal B, Shani G, Cohen O, Kissil JL, Kimchi A (2000) Death-associated protein kinase-related protein 1, a novel serine/threonine kinase involved in apoptosis. Mol Cell Biol 20:1044–1054
Inbal B, Bialik S, Sabanay I, Shani G, Kimchi A (2002) DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death. J Cell Biol 157:455–468
Mills KR, Reginato M, Debnath J, Queenan B, Brugge JS (2004) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is required for induction of autophagy during lumen formation in vitro. Proc Natl Acad Sci USA 101:3438–3443
Peter ME, Krammer PH (2003) The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 10:26–35
Thorburn J, Moore F, Rao A et al (2005) Selective inactivation of a Fas-associated death domain protein (FADD)-dependent apoptosis and autophagy pathway in immortal epithelial cells. Mol Biol Cell 16:1189–1199
Acknowledgments
Institutional funds from the Centre National de la Recherche Scientifique (CNRS) and the University (UM1), and grants from SIDACTION and the Agence Nationale de Recherches sur Le SIDA (ANRS) supported this work. L. Espert was the recipient of a fellowship from SIDACTION.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Espert, L., Codogno, P. & Biard-Piechaczyk, M. Involvement of autophagy in viral infections: antiviral function and subversion by viruses. J Mol Med 85, 811–823 (2007). https://doi.org/10.1007/s00109-007-0173-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-007-0173-6